RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00126672 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Nonmalignant Neoplasm
Tuberous Sclerosis
Lymphangioleimyomatosis
Kidney Angiomyolipoma

Interventions

DRUG: Rapamycin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]